Gut microbiota metabolites for sweetening type I diabetes
- PMID: 28757611
- PMCID: PMC5811683
- DOI: 10.1038/cmi.2017.65
Gut microbiota metabolites for sweetening type I diabetes
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Comment on
-
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.Nat Immunol. 2017 May;18(5):552-562. doi: 10.1038/ni.3713. Epub 2017 Mar 27. Nat Immunol. 2017. PMID: 28346408
References
-
- Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604. - PubMed
-
- Paun A, Yau C, Danska JS. The influence of the microbiome on Type 1 diabetes. J Immunol 2017; 198: 590–595. - PubMed
-
- Marino E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol 2017; 18: 552–562. - PubMed
-
- Kolb H, von Herrath M. Immunotherapy for Type 1 diabetes: why do current protocols not halt the underlying disease process? Cell Metab 2017; 25: 233–241. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical